Immediate Impact

1 by Nobel laureates 56 standout
Sub-graph 1 of 25

Citing Papers

An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Strategies to reduce the risks of mRNA drug and vaccine toxicity
2024 Standout
3 intermediate papers

Works of Michelle Frascella being referenced

Co-administration With the Pharmacological Chaperone AT1001 Increases Recombinant Human α-Galactosidase A Tissue Uptake and Improves Substrate Reduction in Fabry Mice
2012
The Pharmacological Chaperone 1-Deoxygalactonojirimycin Reduces Tissue Globotriaosylceramide Levels in a Mouse Model of Fabry Disease
2009

Author Peers

Author Last Decade Papers Cites
Michelle Frascella 304 121 82 137 10 359
Karen M. Ashe 301 121 48 84 9 379
Linda Berná 346 145 45 93 11 405
Phuong T. Tieu 233 94 59 90 8 332
Sylvie Duthel 275 50 56 102 9 348
Mario A. Cabrera-Salazar 319 95 29 69 11 389
Sabrina Eichler 243 90 28 76 13 314
Carole Elbin 312 109 64 59 8 363
Marie Jackson 227 91 48 63 21 375
Jessica de Ruijter 322 160 86 62 11 394
Yasmina Amraoui 287 75 25 84 15 367

All Works

Loading papers...

Rankless by CCL
2026